✦ LIBER ✦

Cyclin D-dependent kinases, INK4 inhibitors and cancer

✍ Scribed by Sagrario Ortega; Marcos Malumbres; Mariano Barbacid

Book ID: 114222820
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 437 KB
Volume: 1602
Category: Article
ISSN: 0304-419X
DOI: 10.1016/s0304-419x(02)00037-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure of the cyclin-dependent kinase

Structure of the cyclin-dependent kinase inhibitor p19Ink4d

✍ Laue, Ernest D.; Luh, Frederich Y.; Archer, Sharon J.; Domaille, Peter J.; Smith 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 693 KB

p19Ink4d and p18Ink4c cyclin-dependent k

p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis

✍ Gregory M. Buchold; Patricia L. Magyar; Ramamani Arumugam; Mary M. Lee; Deborah 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

The p19INK4D Cyclin dependent kinase inh

The p19INK4D Cyclin dependent kinase inhibitor gene is altered in osteosarcoma

✍ Miller, C W; Yeon, C; Aslo, A; Mendoza, S; Aytac, U; Koeffler, H P 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 345 KB

Inhibitors of cyclin-dependent kinase an

Inhibitors of cyclin-dependent kinase and cancer

✍ J. R. Biggs; A. S. Kraft 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 621 KB

Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an

Cdk pathway: Cyclin-dependent kinases an

Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors

✍ Diana M. Gitig; Andrew Koff 📂 Article 📅 2001 🏛 Humana Press Inc 🌐 English ⚖ 117 KB

Cyclin-dependent kinase inhibitors for t

Cyclin-dependent kinase inhibitors for treating cancer

✍ Peter L. Toogood 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

## Abstract Cyclin dependent kinases (Cdks) are essential enzymes for the control of cell cycle progression. Inhibitors of cyclin‐dependent kinases are anticipated to possess therapeutic utility against a wide variety of proliferative diseases, especially cancer. The field of published small molecu